Segment & Geographic Data
Reported Filing Data
API & CSV Delivery
111 Inc's Business Segments
111 Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of 2025 ((Dec 31 2025))
Reportable Segments
-
Largest Segment
-
Total Revenue
$ 1,747
Regions Reported
-
Annual Results
Revenue by Product & Service Category - FY2025
- Business to Business B2b Business0%
- Drugs0%
- Nutritional Supplements24.9%
- Other Products13.4%
- Business to Consumer B2c Business12.8%
- Product12.8%
- Medical Supplies and Devices8.7%
- Mp Service3.2%
- Service Other1.6%
- Service0.7%
Revenue by Product & Service Category - FY2025
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Business to Business B2b Business | $ 12,247 | - |
| Drugs | $ 11,650 | - |
| Nutritional Supplements | $ 435 | 24.9% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
Description of 111 Inc
111 Inc, also known as 111, is a leading digital healthcare platform company in China that aims to provide innovative, integrated solutions to customers and partners in the healthcare industry. The company was founded in Shanghai in 2010 and has since expanded to become one of the largest digital healthcare platforms in China.
111 operates several business segments that are designed to cater to the various needs of its customers. The company's main business segments are:
Pharmacy and healthcare services - this segment provides customers with online and offline healthcare services and prescription drug delivery services. The company operates a network of licensed drug stores and medical clinics that offer a range of healthcare services.
B2B pharmaceutical supply chain - this segment connects pharmaceutical manufacturers, distributors, hospitals and other healthcare providers through its digital platform, providing an integrated supply chain solution.
Insurance and healthcare management - a business segment that focuses on providing insurance companies with health management services and insurance products.
111's core services include providing pharmacy and healthcare services, a digital hospital platform and B2B pharmaceutical supply chain services. The company's digital hospital platform operates through its subsidiary DXY, which is a platform that connects patients, doctors and hospitals through its online and offline services. DXY is one of the largest online medical portals in China with over 20 million registered users.
In addition to its core services, 111 has also developed a range of innovative technology products that enhance its service offering. For example, the company's AI technology and big data analytics are used to improve patient experience and improve healthcare outcomes.
111 has a strong presence in China's major cities and has expanded to over 30 provinces and municipalities, covering over 90% of China's population. The company has also established strategic partnerships with leading pharmaceutical companies and healthcare providers in China.
111 Inc is listed on the NASDAQ exchange under the ticker symbol YI. The company has won several awards, including being recognized as an innovative company at the 2019 World Artificial Intelligence Conference.
111 operates several business segments that are designed to cater to the various needs of its customers. The company's main business segments are:
Pharmacy and healthcare services - this segment provides customers with online and offline healthcare services and prescription drug delivery services. The company operates a network of licensed drug stores and medical clinics that offer a range of healthcare services.
B2B pharmaceutical supply chain - this segment connects pharmaceutical manufacturers, distributors, hospitals and other healthcare providers through its digital platform, providing an integrated supply chain solution.
Insurance and healthcare management - a business segment that focuses on providing insurance companies with health management services and insurance products.
111's core services include providing pharmacy and healthcare services, a digital hospital platform and B2B pharmaceutical supply chain services. The company's digital hospital platform operates through its subsidiary DXY, which is a platform that connects patients, doctors and hospitals through its online and offline services. DXY is one of the largest online medical portals in China with over 20 million registered users.
In addition to its core services, 111 has also developed a range of innovative technology products that enhance its service offering. For example, the company's AI technology and big data analytics are used to improve patient experience and improve healthcare outcomes.
111 has a strong presence in China's major cities and has expanded to over 30 provinces and municipalities, covering over 90% of China's population. The company has also established strategic partnerships with leading pharmaceutical companies and healthcare providers in China.
111 Inc is listed on the NASDAQ exchange under the ticker symbol YI. The company has won several awards, including being recognized as an innovative company at the 2019 World Artificial Intelligence Conference.
111 Inc is a Chinese integrated online and offline healthcare platform that provides various healthcare products, services, and solutions. They offer several segments, products, and services that cater to different healthcare needs:
Segments:
1. Pharmaceuticals segment: 111 Inc has a pharmaceutical supply chain management system that provides one-stop purchase and distribution services for pharmaceutical and healthcare products.
2. Omni-channel patient management segment: This segment involves providing healthcare services through digital channels such as online consultations, medical prescriptions, and follow-up care services.
3. Direct-to-consumer segment: This segment focuses on providing pharmaceutical and healthcare products directly to consumers through online and offline channels.
Products and Services:
1. Pharmacy services: 111 Inc operates an online pharmacy platform that offers prescription and over-the-counter medications as well as medical devices and consumables.
2. Medical consultations: They offer online medical consultation services with qualified doctors through their digital channels. Patients can receive medical consultations and prescription drugs through the platform.
3. Health management services: 111 Inc provides health management services that include chronic disease management, health screening, and wellness management programs.
4. Data services: 111 Inc collects and manages healthcare data, including electronic medical records, patient information, and medical research data.
5. Medical supply chain management: They offer end-to-end supply chain management services for pharmaceutical and healthcare products, including product sourcing, procurement, warehousing, and logistics.
6. Technology solutions: They provide technology solutions such as medical AI applications, telemedicine solutions, and virtual reality technology for medical education and training.
Overall, 111 Inc offers a comprehensive range of products and services designed to provide efficient and effective healthcare solutions and improve the quality of life for patients. The company's main focus is to integrate online and offline channels, ensuring access to the best possible care to all patients.
Segments:
1. Pharmaceuticals segment: 111 Inc has a pharmaceutical supply chain management system that provides one-stop purchase and distribution services for pharmaceutical and healthcare products.
2. Omni-channel patient management segment: This segment involves providing healthcare services through digital channels such as online consultations, medical prescriptions, and follow-up care services.
3. Direct-to-consumer segment: This segment focuses on providing pharmaceutical and healthcare products directly to consumers through online and offline channels.
Products and Services:
1. Pharmacy services: 111 Inc operates an online pharmacy platform that offers prescription and over-the-counter medications as well as medical devices and consumables.
2. Medical consultations: They offer online medical consultation services with qualified doctors through their digital channels. Patients can receive medical consultations and prescription drugs through the platform.
3. Health management services: 111 Inc provides health management services that include chronic disease management, health screening, and wellness management programs.
4. Data services: 111 Inc collects and manages healthcare data, including electronic medical records, patient information, and medical research data.
5. Medical supply chain management: They offer end-to-end supply chain management services for pharmaceutical and healthcare products, including product sourcing, procurement, warehousing, and logistics.
6. Technology solutions: They provide technology solutions such as medical AI applications, telemedicine solutions, and virtual reality technology for medical education and training.
Overall, 111 Inc offers a comprehensive range of products and services designed to provide efficient and effective healthcare solutions and improve the quality of life for patients. The company's main focus is to integrate online and offline channels, ensuring access to the best possible care to all patients.